# url

id: jovr-10185
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10185&domain=pdf&date_stamp=2019-07-17


id: jovr-11585
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11585&domain=pdf&date_stamp=2019-07-17


id: jovr-10809
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10809&domain=pdf&date_stamp=2019-07-17


id: jovr-13771
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i3.13771&domain=pdf&date_stamp=2019-07-17


id: jovr-10163
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10163&domain=pdf&date_stamp=2019-07-17


id: jovr-10181
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10181&domain=pdf&date_stamp=2019-07-17


id: jovr-10167
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10167&domain=pdf&date_stamp=2019-07-17


id: jovr-11568
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11568&domain=pdf&date_stamp=2019-07-17


id: jovr-10180
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10180&domain=pdf&date_stamp=2019-07-17


id: jovr-10176
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10176&domain=pdf&date_stamp=2019-07-17


id: jovr-11576
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11576&domain=pdf&date_stamp=2019-07-17


id: jovr-11574
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11574&domain=pdf&date_stamp=2019-07-17


id: jovr-12325
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12325&domain=pdf&date_stamp=2019-07-17


id: jovr-10173
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10173&domain=pdf&date_stamp=2019-07-17


id: jovr-10166
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10166&domain=pdf&date_stamp=2019-07-17


id: jovr-12298
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12298&domain=pdf&date_stamp=2019-07-17


id: jovr-12315
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12315&domain=pdf&date_stamp=2019-07-17


id: jovr-12350
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12350&domain=pdf&date_stamp=2019-07-17


id: jovr-11573
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11573&domain=pdf&date_stamp=2019-07-17


id: jovr-11582
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11582&domain=pdf&date_stamp=2019-07-17


id: jovr-10172
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10172&domain=pdf&date_stamp=2019-07-17


id: jovr-12349
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12349&domain=pdf&date_stamp=2019-07-17


id: jovr-10182
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10182&domain=pdf&date_stamp=2019-07-17


id: jovr-12720
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12720&domain=pdf&date_stamp=2019-07-17


id: jovr-10184
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10184&domain=pdf&date_stamp=2019-07-17


id: jovr-12734
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12734&domain=pdf&date_stamp=2019-07-17


id: jovr-12352
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12352&domain=pdf&date_stamp=2019-07-17


id: jovr-10168
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10168&domain=pdf&date_stamp=2019-07-17


id: jovr-13773
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i3.13773&domain=pdf&date_stamp=2019-07-17


id: jovr-12346
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12346&domain=pdf&date_stamp=2019-07-17


id: jovr-13183
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13183&domain=pdf&date_stamp=2019-07-17


id: jovr-10183
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10183&domain=pdf&date_stamp=2019-07-17


id: jovr-11567
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11567&domain=pdf&date_stamp=2019-07-17


id: jovr-12314
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12314&domain=pdf&date_stamp=2019-07-17


id: jovr-10788
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10788&domain=pdf&date_stamp=2019-07-17


id: jovr-10164
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10164&domain=pdf&date_stamp=2019-07-17


id: jovr-10792
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10792&domain=pdf&date_stamp=2019-07-17


id: jovr-10791
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10791&domain=pdf&date_stamp=2019-07-17


id: jovr-13184
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13184&domain=pdf&date_stamp=2019-07-17


id: jovr-12732
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12732&domain=pdf&date_stamp=2019-07-17


id: jovr-10795
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10795&domain=pdf&date_stamp=2019-07-17


id: jovr-10795
domain: docs.google.com
url:
  https://docs.google.com/forms/d/e/1faipqlsfpclv5xi7dzekrgx_wawjth_mdyvotd5rxff3x3m6c7gsfka/viewform?usp=sf_link


id: jovr-12303
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12303&domain=pdf&date_stamp=2019-07-17


id: jovr-10786
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10786&domain=pdf&date_stamp=2019-07-17


id: jovr-10825
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10825&domain=pdf&date_stamp=2019-07-17


id: jovr-11580
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11580&domain=pdf&date_stamp=2019-07-17


id: jovr-10797
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10797&domain=pdf&date_stamp=2019-07-17


id: jovr-10169
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10169&domain=pdf&date_stamp=2019-07-17


id: jovr-13185
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13185&domain=pdf&date_stamp=2019-07-17


id: jovr-12343
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12343&domain=pdf&date_stamp=2019-07-17


id: jovr-4796
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.jovr_109_16&domain=pdf&date_stamp=2019-07-17


id: jovr-12294
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12294&domain=pdf&date_stamp=2019-07-17


id: jovr-10804
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10804&domain=pdf&date_stamp=2019-07-17


id: jovr-10804
domain: clinicaltrials.gov
url:
  https://clinicaltrials.gov/ct2/show/nct02623426?cond=macular+oedema+ranibizumab+v.+intravitreal+anti-inflammatory+therapy+trial&draw=2&rank=1


id: jovr-10804
domain: www.businesswire.com
url:
  https://www.businesswire.com/news/home/20191011005298/en/eyevensys-presents-initial-data-from-phase-iii-trial-of-innovative-non-viral-gene-therapy-for-ocular-diseases-at-11th-annual-ophthalmology-innovation-summit


id: jovr-11586
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11586&domain=pdf&date_stamp=2019-07-17


id: jovr-10785
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10785&domain=pdf&date_stamp=2019-07-17


id: jovr-13182
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13182&domain=pdf&date_stamp=2019-07-17


id: jovr-10793
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10793&domain=pdf&date_stamp=2019-07-17


id: jovr-10794
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10794&domain=pdf&date_stamp=2019-07-17


id: jovr-12345
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12345&domain=pdf&date_stamp=2019-07-17


id: jovr-12723
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12723&domain=pdf&date_stamp=2019-07-17


id: jovr-12342
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12342&domain=pdf&date_stamp=2019-07-17


id: jovr-11577
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11577&domain=pdf&date_stamp=2019-07-17


id: jovr-10179
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10179&domain=pdf&date_stamp=2019-07-17


id: jovr-10170
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10170&domain=pdf&date_stamp=2019-07-17


id: jovr-13181
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13181&domain=pdf&date_stamp=2019-07-17


id: jovr-11570
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11570&domain=pdf&date_stamp=2019-07-17


id: jovr-13180
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13180&domain=pdf&date_stamp=2019-07-17


id: jovr-12296
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12296&domain=pdf&date_stamp=2019-07-17


id: jovr-12719
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12719&domain=pdf&date_stamp=2019-07-17


id: jovr-12719
domain: www.fda.gov
url:
  www.fda.gov/news-events/press-announcements/fdapermits-marketing-artificial-intelligence-based-devicedetect-certain-diabetes-related-eye


id: jovr-12719
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye


id: jovr-12725
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12725&domain=pdf&date_stamp=2019-07-17


id: jovr-13187
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13187&domain=pdf&date_stamp=2019-07-17


id: jovr-12351
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12351&domain=pdf&date_stamp=2019-07-17


id: jovr-13178
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13178&domain=pdf&date_stamp=2019-07-17


id: jovr-11571
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11571&domain=pdf&date_stamp=2019-07-17


id: jovr-12721
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12721&domain=pdf&date_stamp=2019-07-17


id: jovr-10165
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10165&domain=pdf&date_stamp=2019-07-17


id: jovr-12731
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12731&domain=pdf&date_stamp=2019-07-17


id: jovr-11569
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11569&domain=pdf&date_stamp=2019-07-17


id: jovr-12735
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12735&domain=pdf&date_stamp=2019-07-17


id: jovr-12344
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12344&domain=pdf&date_stamp=2019-07-17


id: jovr-12728
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12728&domain=pdf&date_stamp=2019-07-17


id: jovr-11578
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11578&domain=pdf&date_stamp=2019-07-17


id: jovr-11572
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11572&domain=pdf&date_stamp=2019-07-17


id: jovr-10796
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10796&domain=pdf&date_stamp=2019-07-17


id: jovr-10789
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10789&domain=pdf&date_stamp=2019-07-17


id: jovr-10789
domain: ec.europa.eu
url:
  http://ec.europa.eu/eurostat/statistics-explained/index.php?title=surgical_operations_and_procedures_statistics&oldid=27060


id: jovr-10175
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10175&domain=pdf&date_stamp=2019-07-17


id: jovr-7445
domain: www.iapb.org
url:
  https://www.iapb.org/news/wha-73covid-19-eye-health-and-iapb-statement-on-behalf-ofthe-global-eye-care-sector/


id: jovr-7445
domain: www.who.int
url:
  https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19---12-march-2020


id: jovr-7445
domain: www.who.int
url:
  https://www.who.int/publications/i/item/advice-on-the-use-of-masks-the-community-during-home-care-and-in-health-care-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak


id: jovr-7445
domain: www.iapb.org
url:
  https://www.iapb.org/news/wha-73-covid-19-eye-health-and-iapb-statement-on-behalf-of-the-global-eye-care-sector/


id: jovr-7445
domain: www.emro.who.int
url:
  http://www.emro.who.int/media/news/statement-by-regional-director-dr-ahmed-al-mandhari-on-covid-19.html


id: jovr-13783
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i3.13783&domain=pdf&date_stamp=2019-07-17


id: jovr-13774
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i3.13774&domain=pdf&date_stamp=2019-07-17


id: jovr-11575
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i3.11575&domain=pdf&date_stamp=2019-07-17


id: jovr-10805
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10805&domain=pdf&date_stamp=2019-07-17


id: jovr-10805
domain: www.who.int
url:
  https://www.who.int/docs/defaultsource/coronaviruse/who-china-joint-mission-on-covid-19final-report.pdf


id: jovr-12306
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i4.12306&domain=pdf&date_stamp=2019-07-17


id: jovr-12729
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12729&domain=pdf&date_stamp=2019-07-17


id: jovr-10171
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10171&domain=pdf&date_stamp=2019-07-17


id: jovr-7464
domain: www.ctvnews.ca
url:
  https://www.ctvnews.ca/w5/canadian-ophthalmologicalsociety-and-canadian-cornea-external-disease-andrefactive-surgery-society-statement-to-ctv-news-andw5-1.4368071


id: jovr-7464
domain: www.ctvnews.ca
url:
  www.ctvnews.ca/health/painful-side-effects-from-lasereye-surgery-linked-to-man-s-suicide-family-1.4196890


id: jovr-7464
domain: www.ctvnews.ca
url:
  https://www.ctvnews.ca/w5/canadian-ophthalmological-society-and-canadian-cornea-external-disease-and-refactive-surgery-society-statement-to-ctv-news-and-w5-1.4368071


id: jovr-7464
domain: www.usatoday.com
url:
  https://www.usatoday.com/story/news/nation/2018/12/18/meteorologist-jessica-starr-death-suicide-lasik-questions/2346863002


id: jovr-7464
domain: www.ctvnews.ca
url:
  https://www.ctvnews.ca/health/painful-side-effects-from-laser-eye-surgery-linked-to-man-s-suicide-family-1.4196890


id: jovr-13780
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i3.13780&domain=pdf&date_stamp=2019-07-17


id: jovr-13777
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i3.13777&domain=pdf&date_stamp=2019-07-17


id: jovr-13777
domain: eyewire.news
url:
  https://eyewire.news/articles/analysis-55-percent-feweramericans-sought-hospital-care-in-march-april-due-tocovid-19/?c4src=article:infinite-scroll


id: jovr-13777
domain: www.rcophth.ac.uk
url:
  https://www.rcophth.ac.uk/standards-and-guidance/covid-19-resources/national-government-health-organisations-updates


id: jovr-12724
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i1.12724&domain=pdf&date_stamp=2019-07-17


id: jovr-13186
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13186&domain=pdf&date_stamp=2019-07-17


id: jovr-13776
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i3.13776&domain=pdf&date_stamp=2019-07-17


id: jovr-7466
domain: www.college-optometrists.org
url:
  https://www.college-optometrists.org/the-college/media-hub/news-listing/coronavirus-covid-19-guidance-for-optometrists.html


id: jovr-13779
domain: crossmark.crossref.org
url:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i3.13779&domain=pdf&date_stamp=2019-07-17


id: jovr-8257
domain: bhw.hrsa.gov
url:
  https://bhw.hrsa.gov/sites/default/files/bureauhealth-workforce/data-research/primary-care-nationalprojections-2013-2025.pdf


id: jovr-8257
domain: www.aamc.org
url:
  https://www.aamc.org/news-insights/press-releases/new-findings-confirm-predictions-physician-shortage


id: jovr-8257
domain: bhw.hrsa.gov
url:
  https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/primary-care-national-projections-2013-2025.pdf


id: jovr-8257
domain: www.aamc.org
url:
  https://www.aamc.org/news-insights/press-releases/new-aamc-report-confirms-growing-physician-shortage


id: jovr-7458
domain: www.euro.who.int
url:
  http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic


id: jovr-7458
domain: www.entuk.org
url:
  https://www.entuk.org/sites/default/files/files/loss%20of%20sense%20of%20smell%20as%20marker%20of%20covid.pdf


id: jovr-7458
domain: www.rcophth.ac.uk
url:
  https://www.rcophth.ac.uk/wp-content/uploads/2020/03/rcophth-management-of-ophthalmology-services-during-the-covid-pandemic-280320.pdf


id: jovr-7458
domain: radiology.ucsf.edu
url:
  https://radiology.ucsf.edu/sites/radiology.ucsf.edu/files/wysiwyg/patientcare/patient-safety/covid-19/lin_lab_covid_presentation_2020-03-16.pdf


id: jovr-7458
domain: www.battelle.org
url:
  https://www.battelle.org/docs/default-source/commercial-offerings/industry-solutions/instructions-for-healthcare-facilities---03-29-2020---615pm-revision.pdf


id: jovr-7793
domain: retinatoday.com
url:
  https://retinatoday.com/articles/2015july-aug/retinal-hemangiomas-understanding-clinicalfeatures-imaging-and-therapies


id: jovr-7793
domain: retinatoday.com
url:
  https://retinatoday.com/articles/2015-july-aug/retinal-hemangiomas-understanding-clinical-features-imaging-and-therapies


id: jovr-9433
domain: www.sduhealth.org.uk
url:
  https://www.sduhealth.org.uk/policy-strategy/engagement-resources/nhs-carbon-reduction-strategy-2009.aspx


id: jovr-9433
domain: assets.publishing.service.gov.uk
url:
  https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/69314/pb13625-emission-factor-methodology-paper-110905.pdf


id: jovr-9433
domain: digital.nhs.uk
url:
  https://digital.nhs.uk/data-and-information/publications/statistical/estates-returns-information-collection/estates-return-information-collection-2016-17


id: jovr-9755
domain: www.migrationpolicy.org
url:
  https://www.migrationpolicy.org/article/middle-easternand-north-african-immigrants-united-states-2016


id: jovr-9755
domain: www.migrationpolicy.org
url:
  https://www.migrationpolicy.org/article/middle-eastern-and-north-african-immigrants-united-states-2016


id: jovr-9754
domain: www.omicsonline.org
url:
  https://www.omicsonline.org/open-access/probioticlactobacillus-species-strengthen-intestinal-barrierfunction-andtight-junction-integrity-in-experimentalnecrotizing-ent-2329-8901-1000159.php?aid=85246


id: jovr-9754
domain: www.omicsonline.org
url:
  https://www.omicsonline.org/open-access/probiotic-lactobacillus-species-strengthen-intestinal-barrier-function-andtight-junction-integrity-in-experimental-necrotizing-ent-2329-8901-1000159.php?aid=85246


# ent

id: jovr-12415
sid: 5
eid: 4
type: PERSON
entity:
  sabermoghaddam ranjbar mehdi moddareszadeh alireza esmaeili mehdi mazloumi alireza hedayatfar mehran zarei-ghanavati alireza khodabandeh


id: jovr-12415
sid: 5
eid: 5
type: PERSON
entity:
  mehrdad mohammadpour alireza peyman mehrnaz atighehchian alireza ramezani mehrnaz geranmayeh amir faramarzi mohadeseh


id: jovr-12415
sid: 6
eid: 4
type: PERSON
entity:
  nowroozzadeh arezoo miraftabi mohammad reza niyousha arezoo miraftabi mohammad reza peyman asieh heirani-tabasi mohammad taher rajabi azadeh doozandeh mohammad-nasser hashemian bagher hoseini mohammad-reza


id: jovr-10164
sid: 17
eid: 1
type: ORG
entity:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i1.10164&domain=pdf&date_stamp=2019-07-17 two


id: jovr-5963
sid: 15
eid: 3
type: PERSON
entity:
  e http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v15i1.5963&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-5473
sid: 46
eid: 1
type: FAC
entity:
  http://www.medtronic.com/us-en/patients/electromagnetic-guide/medical-dental.html http://www.medtronic.com/us-en/patients/electromagnetic-guide/medical-dental.html https://knepublishing.com/index.php/jovr


id: jovr-12719
sid: 55
eid: 1
type: EVENT
entity:
  https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye


id: jovr-12719
sid: 55
eid: 2
type: PERSON
entity:
  https://www.aao.org/headline/autonomous-diabetic-retinopathy-screening-system-g https://www.aao.org/headline/autonomous-diabetic-retinopathy-screening-system-g https://ui.adsabs.harvard.edu/abs/2015arxiv150504597r https://ui.adsabs.harvard.edu/abs/2015arxiv150504597r


id: jovr-13181
sid: 19
eid: 1
type: TIME
entity:
  157 http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v18i2.13181&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-10804
sid: 496
eid: 6
type: PERSON
entity:
  https://clinicaltrials.gov/ct2/show/nct02623426?cond=macular+oedema+ranibizumab+v.+intravitreal+anti-inflammatory+therapy+trial&draw=2&rank=1 https://clinicaltrials.gov/ct2/show/nct02623426?cond=macular+oedema+ranibizumab+v.+intravitreal+anti-inflammatory+therapy+trial&draw=2&rank=1 https://clinicaltrials.gov/ct2/show/nct02623426?cond=macular+oedema+ranibizumab+v.+intravitreal+anti-inflammatory+therapy+trial&draw=2&rank=1 https://clinicaltrials.gov/ct2/show/nct02623426?cond=macular+oedema+ranibizumab+v.+intravitreal+anti-inflammatory+therapy+trial&draw=2&rank=1


id: jovr-10804
sid: 538
eid: 5
type: TIME
entity:
  289 https://www.businesswire.com/news/home/20191011005298/en/eyevensys-presents-initial-data-from-phase-iii-trial-of-innovative-non-viral-gene-therapy-for-ocular-diseases-at-11th-annual-ophthalmology-innovation-summit https://www.businesswire.com/news/home/20191011005298/en/eyevensys-presents-initial-data-from-phase-iii-trial-of-innovative-non-viral-gene-therapy-for-ocular-diseases-at-11th-annual-ophthalmology-innovation-summit https://www.businesswire.com/news/home/20191011005298/en/eyevensys-presents-initial-data-from-phase-iii-trial-of-innovative-non-viral-gene-therapy-for-ocular-diseases-at-11th-annual-ophthalmology-innovation-summit https://www.businesswire.com/news/home/20191011005298/en/eyevensys-presents-initial-data-from-phase-iii-trial-of-innovative-non-viral-gene-therapy-for-ocular-diseases-at-11th-annual-ophthalmology-innovation-summit https://www.businesswire.com/news/home/20191011005298/en/eyevensys-presents-initial-data-from-phase-iii-trial-of-innovative-non-viral-gene-therapy-for-ocular-diseases-at-11th-annual-ophthalmology-innovation-summit


id: jovr-5451
sid: 18
eid: 1
type: PERSON
entity:
  457 http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v14i4.5451&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-10789
sid: 10
eid: 1
type: PERSON
entity:
  e http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v17i2.10789&domain=pdf&date_stamp=2019-07-17 nsaid


id: jovr-7445
sid: 80
eid: 1
type: GPE
entity:
  https://www.iapb.org/news/wha-73covid-19-eye-health-and-iapb-statement-on-behalf-ofthe-global-eye-care-sector/.


id: jovr-7445
sid: 93
eid: 1
type: ORG
entity:
  https://www.iapb.org/news/wha-73-covid-19-eye-health-and-iapb-statement-on-behalf-of-the-global-eye-care-sector/. https://www.iapb.org/news/wha-73-covid-19-eye-health-and-iapb-statement-on-behalf-of-the-global-eye-care-sector/. https://www.iapb.org/news/wha-73-covid-19-eye-health-and-iapb-statement-on-behalf-of-the-global-eye-care-sector/.


id: jovr-7780
sid: 9
eid: 6
type: PERSON
entity:
  493 http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v15i4.7780&domain=pdf&date_stamp=2019-07-17 mesenchymal


id: jovr-13777
sid: 187
eid: 4
type: ORG
entity:
  https://www.rcophth.ac.uk/standards-and-guidance/covid-19-resources/national-government-health-organisations-updates/ https://www.rcophth.ac.uk/standards-and-guidance/covid-19-resources/national-government-health-organisations-updates/ https://www.rcophth.ac.uk/standards-and-guidance/covid-19-resources/national-government-health-organisations-updates/


id: jovr-6728
sid: 39
eid: 1
type: PERSON
entity:
  https://restoresight.org/what-we-do/publications/statistical-report/ https://restoresight.org/what-we-do/publications/statistical-report/


id: jovr-7464
sid: 95
eid: 1
type: PERSON
entity:
  https://www.usatoday.com/story/news/nation/2018/12/18/meteorologist-jessica-starr-death-suicide-lasik-questions/2346863002/ https://www.usatoday.com/story/news/nation/2018/12/18/meteorologist-jessica-starr-death-suicide-lasik-questions/2346863002/


id: jovr-4784
sid: 16
eid: 2
type: LOC
entity:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v14i3.4784&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-7466
sid: 87
eid: 6
type: ORG
entity:
  https://www.eurotimes.org/update-on-covid-19-situation-in-belgium-from-dr-guy-sallet/ https://www.eurotimes.org/update-on-covid-19-situation-in-belgium-from-dr-guy-sallet/ https://www.eurotimes.org/update-on-covid-19-situation-in-belgium-from-dr-guy-sallet/


id: jovr-7466
sid: 88
eid: 1
type: PERSON
entity:
  https://www.rcophth.ac.uk/wp-content/uploads/2020/03/coronavirus-rcophth-key-points-march-19th.pdf https://www.rcophth.ac.uk/wp-content/uploads/2020/03/coronavirus-rcophth-key-points-march-19th.pdf


id: jovr-6742
sid: 16
eid: 3
type: PERSON
entity:
  e http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v15i2.6742&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-7791
sid: 153
eid: 1
type: PERSON
entity:
  https://doi.org/10.1016/j.ajo.2015.09.026 https://doi.org/10.1136/bjophthalmol-2015-307330 https://doi.org/10.1136/bjophthalmol-2015-307330 fovea


id: jovr-9427
sid: 20
eid: 1
type: PRODUCT
entity:
  317 http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i3.9427&domain=pdf&date_stamp=2019-07-17


id: jovr-7463
sid: 19
eid: 3
type: PERSON
entity:
  e http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v15i3.7463&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-9089
sid: 21
eid: 1
type: PERSON
entity:
  e http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i2.9089&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-8257
sid: 182
eid: 5
type: MONEY
entity:
  121 https://bhw.hrsa.gov/health-workforce-analysis/primary-care-2020 https://bhw.hrsa.gov/health-workforce-analysis/primary-care-2020


id: jovr-9751
sid: 160
eid: 4
type: MONEY
entity:
  619 https://fabfoundation.org/resource-folder/pdfs/weinmann_masters_thesis.pdf https://fabfoundation.org/resource-folder/pdfs/weinmann_masters_thesis.pdf


id: jovr-7458
sid: 271
eid: 1
type: PERSON
entity:
  https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/ https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/


id: jovr-9448
sid: 18
eid: 1
type: PERSON
entity:
  521 http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i3.9448&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-9102
sid: 21
eid: 1
type: PERSON
entity:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i2.9102&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-7793
sid: 284
eid: 5
type: ORG
entity:
  https://retinatoday.com/articles/2015-july-aug/retinal-hemangiomas-understanding-clinical-features-imaging-and-therapies https://retinatoday.com/articles/2015-july-aug/retinal-hemangiomas-understanding-clinical-features-imaging-and-therapies https://retinatoday.com/articles/2015-july-aug/retinal-hemangiomas-understanding-clinical-features-imaging-and-therapies


id: jovr-9092
sid: 15
eid: 1
type: PERSON
entity:
  287 http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i2.9092&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-9441
sid: 18
eid: 4
type: PERSON
entity:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i3.9441&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-9433
sid: 271
eid: 4
type: MONEY
entity:
  375 https://unfccc.int/resource/docs/publications/08_unfccc_kp_ref_manual.pdf https://unfccc.int/resource/docs/publications/08_unfccc_kp_ref_manual.pdf


id: jovr-9433
sid: 272
eid: 1
type: PERSON
entity:
  https://www.sduhealth.org.uk/policy-strategy/engagement-resources/nhs-carbon-reduction-strategy-2009.aspx https://www.sduhealth.org.uk/policy-strategy/engagement-resources/nhs-carbon-reduction-strategy-2009.aspx


id: jovr-9433
sid: 276
eid: 1
type: ORG
entity:
  https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/69314/pb13625-emission-factor-methodology-paper-110905.pdf https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/69314/pb13625-emission-factor-methodology-paper-110905.pdf https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/69314/pb13625-emission-factor-methodology-paper-110905.pdf https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/69314/pb13625-emission-factor-methodology-paper-110905.pdf


id: jovr-9433
sid: 276
eid: 2
type: FAC
entity:
  https://calculator.carbonfootprint.com/calculator.aspx?lang=en-gb&tab=3 https://calculator.carbonfootprint.com/calculator.aspx?lang=en-gb&tab=3


id: jovr-8255
sid: 38
eid: 5
type: ORG
entity:
  http://www.jovr.org http://www.jovr.org https://www.journals.elsevier.com/journal-of-current-ophthalmology https://www.journals.elsevier.com/journal-of-current-ophthalmology


id: jovr-9087
sid: 315
eid: 1
type: PRODUCT
entity:
  https://doi.org/10.1111/aos.14570 https://doi.org/10.1212/cpj.0000000000000897 https://doi.org/10.1212/cpj.0000000000000897


id: jovr-9428
sid: 151
eid: 2
type: PERSON
entity:
  https://www.maxwell.vrac.puc-rio.br/busca_etds.php?strsecao=resultado&nrseq=10706@1 https://www.maxwell.vrac.puc-rio.br/busca_etds.php?strsecao=resultado&nrseq=10706@1


id: jovr-9091
sid: 14
eid: 2
type: PERSON
entity:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i2.9091&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-9755
sid: 15
eid: 1
type: ORG
entity:
  knowledge e http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i4.9755&domain=pdf&date_stamp=2019-07-17


id: jovr-9438
sid: 19
eid: 2
type: PERSON
entity:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i3.9438&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr sturge-weber


id: jovr-9754
sid: 70
eid: 5
type: PERSON
entity:
  parabacteroides parabacteroides distasonis alistipes alistipes finegoldii prevotella prevotella spp.


id: jovr-9754
sid: 249
eid: 6
type: FAC
entity:
  https://eyewiki.aao.org/treatment_of_uveitis http://journal.frontiersin.org/article/10.3389/fcimb.2012.00104/abstract http://journal.frontiersin.org/article/10.3389/fcimb.2012.00104/abstract


id: jovr-9754
sid: 262
eid: 1
type: FAC
entity:
  https://www.omicsonline.org/open-access/probioticlactobacillus-species-strengthen-intestinal-barrierfunction-andtight-junction-integrity-in-experimentalnecrotizing-ent-2329-8901-1000159.php?aid=85246 35


id: jovr-8259
sid: 13
eid: 2
type: PERSON
entity:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i1.8259&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/jovr


id: jovr-9432
sid: 18
eid: 2
type: PERSON
entity:
  http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v16i3.9432&domain=pdf&date_stamp=2019-07-17 smartphone bleb


# pos

id: jovr-7445
sid: 93
tid: 3
pos: PROPN
token:
  https://www.iapb.org/news/wha-73-covid-19-eye-health-and-iapb-statement-on-behalf-of-the-global-eye-care-sector/.

lemma:
  https://www.iapb.org/news/wha-73-covid-19-eye-health-and-iapb-statement-on-behalf-of-the-global-eye-care-sector/.


id: jovr-13777
sid: 187
tid: 18
pos: PROPN
token:
  https://www.rcophth.ac.uk/standards-and-guidance/covid-19-resources/national-government-health-organisations-updates/

lemma:
  https://www.rcophth.ac.uk/standards-and-guidance/covid-19-resources/national-government-health-organisations-updates/


id: jovr-7464
sid: 95
tid: 5
pos: PROPN
token:
  https://www.usatoday.com/story/news/nation/2018/12/18/meteorologist-jessica-starr-death-suicide-lasik-questions/2346863002/

lemma:
  https://www.usatoday.com/story/news/nation/2018/12/18/meteorologist-jessica-starr-death-suicide-lasik-questions/2346863002/


id: jovr-7793
sid: 284
tid: 36
pos: NOUN
token:
[cell repeats an earlier one in this file: 120 characters]

lemma:
  https://retinatoday.com/articles/2015-july-aug/retinal-hemangiomas-understanding-clinical-features-imaging-and-therapie


